Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Rick Wise
STIF

Rick Wise

Stifel Nicolaus
Wall Street Analyst
★★★★★
#55
on 13Foresight · ranked by our own returns
72%
Success Rate
+13.1%
Average Return
51 of 71 calls profitable · +39.2% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 72% of Rick Wise's ratings turned a profit when each position was held for 1 year — averaging +13.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.
Rick's Stock Coverage 29 ratings · 2026-11-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
BAX
Baxter International
 Oct 30, 2026 HOLD Buy
+45.2% avg upside
23 analysts
$25.00
8.65% Upside
 +14.5% ·
GEHC
GE Healthcare Technologies Inc
 Oct 29, 2026 BUY Strong Buy
+10.2% avg upside
23 analysts
$90.00
17.50% Upside
 +7.1% ·
LUNG
Pulmonx
 Oct 28, 2026 BUY Buy
+152.1% avg upside
9 analysts
$4.00
33.09% Upside
 +11.1% ·
KIDS
OrthoPediatrics
 Oct 28, 2026 BUY Strong Buy
+9.5% avg upside
10 analysts
$27.00
12.48% Downside
 +9.1% ·
BSX
Boston Scientific
 Oct 26, 2026 BUY Strong Buy
+43.0% avg upside
38 analysts
$55.00
31.08% Upside
 -1.7% ·
ABT
Abbott Laboratories
 Oct 22, 2026 BUY Strong Buy
+8.5% avg upside
36 analysts
$120.00
13.08% Upside
 +7.2% ·
ISRG
Intuitive Surgical
 Oct 21, 2026 BUY Strong Buy
+12.0% avg upside
37 analysts
$550.00
27.22% Upside
 +2.8% ·
JNJ
Johnson & Johnson
 Oct 12, 2026 HOLD Strong Buy
-9.1% avg upside
40 analysts
$260.00
4.87% Downside
 +7.5% ·
SYK
Stryker
 Sep 30, 2026 BUY Strong Buy
+18.5% avg upside
38 analysts
$330.00
12.99% Upside
 +15.8% ·
SOLV
Solventum Corporation
 Sep 18, 2026 BUY Buy
+12.8% avg upside
16 analysts
$100.00
23.04% Upside
 +0.2% ·
ATRC
Atricure
 Sep 17, 2026 BUY Strong Buy
-13.7% avg upside
15 analysts
$65.00
6.15% Upside
 -2.8% ·
KMTS
Kestra Medical Technologies Ltd.
 Sep 15, 2026 BUY Strong Buy
-4.8% avg upside
9 analysts
$30.00
0.96% Upside
 +13.7% ·
MDT
Medtronic
 Sep 02, 2026 HOLD Buy
+4.4% avg upside
38 analysts
$95.00
1.53% Downside
 +10.7% ·
HTFL
HeartFlow, Inc.
 Aug 14, 2026 BUY Strong Buy
-24.3% avg upside
10 analysts
$45.00
23.74% Downside
 +38.9% ·
TMCI
Treace Medical Concepts
 Aug 11, 2026 HOLD Hold
+34.6% avg upside
8 analysts
$4.50
1.58% Upside
 +6.1% ·
BDX
Becton Dickinson
 Aug 11, 2026 BUY Buy
-0.4% avg upside
25 analysts
$195.00
1.37% Downside
 +18.9% ·
AORT
Artivion
 Aug 07, 2026 BUY Strong Buy
+75.4% avg upside
9 analysts
$45.00
99.26% Upside
 -25.9% ·
TSE:PRN
Profound Medical
 Aug 07, 2026 BUY Strong Buy
+114.5% avg upside
11 analysts
$13.96
52.11% Upside
 -1.6% ·
OM
Outset Medical
 Aug 07, 2026 BUY Buy
+314.7% avg upside
8 analysts
$6.00
48.84% Upside
 -15.9% ·
ZBH
Zimmer Biomet Holdings
 Aug 06, 2026 BUY Buy
+20.5% avg upside
39 analysts
$110.00
16.47% Upside
 +7.9% ·
MDLN
Medline
 Aug 06, 2026 BUY Strong Buy
+43.4% avg upside
27 analysts
$45.00
40.10% Upside
 +15.8% ·
LIVN
LivaNova
 Aug 05, 2026 BUY Strong Buy
+1.1% avg upside
15 analysts
$85.00
7.56% Upside
 +15.8% ·
LMAT
Lemaitre Vascular
 Aug 05, 2026 BUY Strong Buy
+21.2% avg upside
16 analysts
$120.00
48.17% Upside
 +3.0% ·
EW
Edwards Lifesciences
 Jul 24, 2026 BUY Strong Buy
+10.0% avg upside
35 analysts
$110.00
19.64% Upside
 +28.0% ·
CNMD
Conmed
 May 01, 2025 HOLD Hold
+48.7% avg upside
12 analysts
$55.00
24.23% Upside
 -35.2% ·
VRAYQ
Viewray
 Jun 03, 2023 HOLD Strong Buy
+558333233.3% avg upside
12 analysts
$1.00
99999900.07% Upside
 · ·
HIND
Vyome Holdings
 Feb 25, 2019 BUY Strong Buy
+1429.6% avg upside
9 analysts
$30.00
1566.65% Upside
 · ·
TNDM
Tandem Diabetes Care
 Aug 22, 2018 HOLD Buy
+64.3% avg upside
29 analysts
$34.00
77.85% Upside
 +77.7% ·
IDXX
Idexx Laboratories
 Nov 08, 2012 HOLD Buy
+30.3% avg upside
19 analysts
 — +21.9% ·
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Rick Wise — Frequently Asked Questions
How accurate are Rick Wise's stock ratings?
Based on the calls 13Foresight could measure, about 70% of Rick's ratings were profitable over a one-year hold, with an average return of +13.0% per rating, or +10.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Rick ranked on 13Foresight?
Rick Wise is currently ranked #55 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Rick cover?
Rick most recently has ratings on BAX, GEHC, LUNG, KIDS, BSX, ABT, ISRG, JNJ, SYK, SOLV, ATRC, KMTS and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.